Are you wondering if there are others in the community living with CML long-term, and whether their condition remains stable?
Many people with CML do live with the condition long-term while maintaining stability. The five-year survival rate for CML is 70 percent, which has improved dramatically from just 22 percent in the Show Full Answer
Are you wondering if there are others in the community living with CML long-term, and whether their condition remains stable?
Many people with CML do live with the condition long-term while maintaining stability. The five-year survival rate for CML is 70 percent, which has improved dramatically from just 22 percent in the 1970s. This means many people are living well beyond five years after diagnosis.
Staying stable with CML often depends on consistent treatment with tyrosine kinase inhibitors (TKIs). Most people with CML need to keep taking these medications long-term to avoid relapse and maintain stability.
Several factors influence how stable your CML remains:
* Which phase of CML you're in (chronic, accelerated, or blast)
* Your age and overall health
* How well you respond to treatment
* Specific genetic mutations in your CML cells
People in the chronic phase who respond well to TKIs tend to have better long-term stability. It's important to stay in close contact with your cancer care team, attend all follow-up appointments, and report any new symptoms promptly.
On MyLeukemiaTeam, members regularly share their experiences living with CML over many years and supporting each other through the journey.
November 30, 2025
Join
Your Privacy Choices
